Cannabis and anxiety: a critical review of the evidence (Q34998397)

5 August 2017

1 reference

title

Cannabis and anxiety: a critical review of the evidence (English)

1 reference

5 August 2017

0 references

7

Paolo Fusar-Poli

0 references

Sagnik Bhattacharyya

Sagnik Bhattacharyya

4

0 references

Philip McGuire

Philip McGuire

6

0 references

Antonio Waldo Zuardi

2

Antonio Waldo Zuardi

1 reference

5 August 2017

5

Zerrin Atakan

1 reference

PubMed ID

19693792

José Alexandre de Souza Crippa

5 August 2017

1

José Alexandre Crippa

1 reference

5 August 2017

Rocio Martín-Santos

3

1 reference

PubMed ID

19693792

5 August 2017

language of work or name

1 reference

1 October 2009

1 reference

5 August 2017

Human Psychopharmacology

1 reference

5 August 2017

24

1 reference

5 August 2017

7

1 reference

5 August 2017

515-523

1 reference

Depersonalization and agoraphobia associated with marijuana use.

5 August 2017

1 reference

Who is using cannabis as a medicine and why: an exploratory study.

21 January 2018

1 reference

Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence

21 January 2018

1 reference

7 January 2021

Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects

1 reference

7 January 2021

Causal association between cannabis and psychosis: examination of the evidence

1 reference

7 January 2021

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

1 reference

7 January 2021

Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers.

1 reference

7 January 2021

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999.

1 reference

7 January 2021

Substance use among young people: the relationship between perceived functions and intentions

1 reference

7 January 2021

5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats

1 reference

7 January 2021

Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial.

1 reference

7 January 2021

Social anxiety and problematic cannabis use: evaluating the moderating role of stress reactivity and perceived coping.

1 reference

7 January 2021

Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence

1 reference

7 January 2021

Review of the validity and significance of cannabis withdrawal syndrome

1 reference

7 January 2021

Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms

1 reference

7 January 2021

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

1 reference

7 January 2021

Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology

1 reference

7 January 2021

Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates

1 reference

7 January 2021

Effects of cannabidiol (CBD) on regional cerebral blood flow

1 reference

7 January 2021

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

7 January 2021

Comorbid cannabis use and panic disorder: short term and long term follow-up study

1 reference

7 January 2021

Marijuana and panic disorder

1 reference

7 January 2021

The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being.

1 reference

7 January 2021

Exploring the association between cannabis use and depression.

1 reference

7 January 2021

Affect dysregulation in cannabis abusers: a study in adolescents and young adults.

1 reference

7 January 2021

The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety

1 reference

7 January 2021

Cannabis dependence and mental health perception amongst people diverted by police after arrest for cannabis-related offending behaviour in Australia.

1 reference

7 January 2021

Early onset cannabis use and psychosocial adjustment in young adults

1 reference

7 January 2021

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing

1 reference

7 January 2021

Co-morbidity of select anxiety, affective, and psychotic disorders with cannabis dependence in Southwest California Indians

1 reference

7 January 2021

The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress.

1 reference

7 January 2021

A single dose study of nabilone, a synthetic cannabinoid

1 reference

7 January 2021

Adverse effects of cannabis

1 reference

7 January 2021

The marijuana withdrawal syndrome: diagnosis and treatment

1 reference

7 January 2021

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

1 reference

7 January 2021

Nefazodone decreases anxiety during marijuana withdrawal in humans

1 reference

7 January 2021

Bupropion SR worsens mood during marijuana withdrawal in humans

1 reference

7 January 2021

Cannabis effects and dependency concerns in long-term frequent users: a missing piece of the public health puzzle

1 reference

7 January 2021

Cannabis and Anxiety and Depression in Young Adults

1 reference

7 January 2021

Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.

1 reference

7 January 2021

Cannabis use and the risk behavior syndrome in Italian university students: are they related to suicide risk?

1 reference

7 January 2021

Cannabis and the brain

1 reference

7 January 2021

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

1 reference

7 January 2021

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

7 January 2021

Can cannabis trigger recurrent panic attacks in susceptible patients?

1 reference

7 January 2021

Genetic and environmental contributions to cannabis dependence in a national young adult twin sample

1 reference

7 January 2021

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

1 reference

7 January 2021

Role of endocannabinoid system in mental diseases

1 reference

7 January 2021

Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: altered responses to cannabinoid exposure

1 reference

7 January 2021

A longitudinal study of cannabis use and mental health from adolescence to early adulthood

1 reference

7 January 2021

Dual diagnosis: a review of etiological theories

1 reference

7 January 2021

The endocannabinoid system: emotion, learning and addiction

1 reference

7 January 2021

Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons

1 reference

7 January 2021

Cannabis, the mind and society: the hash realities

1 reference

7 January 2021

Interactions of marijuana and induced stress: forearm blood flow, heart rate, and skin conductance

1 reference

7 January 2021

Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats.

1 reference

7 January 2021

Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats

1 reference

7 January 2021

Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala

1 reference

7 January 2021

Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.

1 reference

7 January 2021

Cannabis use and mental health in young people: cohort study

1 reference

7 January 2021

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

1 reference

7 January 2021

Sensory, perceptual, motor and cognitive functioning and subjective reports following oral administration of? 9-Tetrahydrocannabinol

1 reference

7 January 2021

Cannabinoid modulation of amygdala reactivity to social signals of threat in humans

1 reference

7 January 2021

Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting

1 reference

7 January 2021

Long-term cannabis use: characteristics of users in an Australian rural area

1 reference

7 January 2021

Early clinical manifestations of cannabis dependence in a community sample

1 reference

7 January 2021

The spectrum of substance use in mood and anxiety disorders

1 reference

7 January 2021

Reasons for cannabis use in psychosis.

1 reference

7 January 2021

Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia

1 reference

7 January 2021

Differences in temperament, character and psychopathology among subjects with different patterns of cannabis use.

1 reference

7 January 2021

Anxiety sensitivity and self-reported reasons for drug use.

1 reference

7 January 2021

Who Seeks Treatment for Cannabis-related Problems?

1 reference

7 January 2021

Cannabis and neurodevelopment: implications for psychiatric disorders.

1 reference

7 January 2021

Substance use disorder comorbidity among inpatient youths with psychiatric disorder.

1 reference

7 January 2021

Psychiatric symptoms in cannabis users

1 reference

7 January 2021

A community survey of adverse effects of cannabis use.

1 reference

7 January 2021

Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population.

1 reference

7 January 2021

Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats.

1 reference

7 January 2021

Psychiatric symptoms in male cannabis users not using other illicit drugs

1 reference

7 January 2021

Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?

1 reference

7 January 2021

A cross-study comparison of cannabis and tobacco withdrawal.

1 reference

7 January 2021

Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol

1 reference

7 January 2021

Endocannabinoid system and stress and anxiety responses.

1 reference

7 January 2021

Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes.

1 reference

7 January 2021

A role for cannabinoid CB1 receptors in mood and anxiety disorders

1 reference

7 January 2021

Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.

1 reference

7 January 2021

Cannabis use in HIV for pain and other medical symptoms

1 reference

7 January 2021

Effects of ipsapirone and cannabidiol on human experimental anxiety

1 reference

7 January 2021

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

1 reference

7 January 2021

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

1 reference

7 January 2021

Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample

1 reference

7 January 2021

Anxiety sensitivity interacts with marijuana use in the prediction of anxiety symptoms and panic-related catastrophic thinking among daily tobacco users

1 reference

7 January 2021

Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1048

1 reference

5 August 2017

1 reference

PubMed ID

19693792